Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benralizumab Patient Access Programme Study: Retrospective, Observational Study in UK Severe Asthma Centres to Describe Patient Characteristics, Treatment Patterns and Outcomes

NCT05932849 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05932849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05932849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benralizumab Patient Access Programme Study: Retrospective, Observational Study in UK Severe Asthma Centres to Describe Patient Characteristics, Treatment Patterns and Outcomes
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 5, 2021
Completion date
February 28, 2022
Enrollment
276 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

asthma